These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16413071)

  • 21. A novel function for the protein tyrosine phosphatase Shp2 during lung branching morphogenesis.
    Tefft D; De Langhe SP; Del Moral PM; Sala F; Shi W; Bellusci S; Warburton D
    Dev Biol; 2005 Jun; 282(2):422-31. PubMed ID: 15950607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate-trapping techniques in the identification of cellular PTP targets.
    Blanchetot C; Chagnon M; Dubé N; Hallé M; Tremblay ML
    Methods; 2005 Jan; 35(1):44-53. PubMed ID: 15588985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexin II binds to SHP2 and this interaction is regulated by HSP70 levels.
    Yoo JC; Hayman MJ
    Biochem Biophys Res Commun; 2007 May; 356(4):906-11. PubMed ID: 17395158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox-regulated affinity of the third PDZ domain in the phosphotyrosine phosphatase PTP-BL for cysteine-containing target peptides.
    van den Berk LC; Landi E; Harmsen E; Dente L; Hendriks WJ
    FEBS J; 2005 Jul; 272(13):3306-16. PubMed ID: 15978037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223.
    Luo M; Reyna S; Wang L; Yi Z; Carroll C; Dong LQ; Langlais P; Weintraub ST; Mandarino LJ
    Endocrinology; 2005 Oct; 146(10):4410-6. PubMed ID: 16020478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based kinetic models of modular signaling protein function: focus on Shp2.
    Barua D; Faeder JR; Haugh JM
    Biophys J; 2007 Apr; 92(7):2290-300. PubMed ID: 17208977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases.
    Flint AJ; Tiganis T; Barford D; Tonks NK
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1680-5. PubMed ID: 9050838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased susceptibility to ischemia-induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2.
    Aoki Y; Huang Z; Thomas SS; Bhide PG; Huang I; Moskowitz MA; Reeves SA
    FASEB J; 2000 Oct; 14(13):1965-73. PubMed ID: 11023980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The src homology 2 domain-containing tyrosine phosphatase 2 regulates primary T-dependent immune responses and Th cell differentiation.
    Salmond RJ; Huyer G; Kotsoni A; Clements L; Alexander DR
    J Immunol; 2005 Nov; 175(10):6498-508. PubMed ID: 16272304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein.
    Huang W; Saberwal G; Horvath E; Zhu C; Lindsey S; Eklund EA
    Mol Cell Biol; 2006 Sep; 26(17):6311-32. PubMed ID: 16914719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor.
    Ravichandran LV; Chen H; Li Y; Quon MJ
    Mol Endocrinol; 2001 Oct; 15(10):1768-80. PubMed ID: 11579209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival.
    Yang W; Klaman LD; Chen B; Araki T; Harada H; Thomas SM; George EL; Neel BG
    Dev Cell; 2006 Mar; 10(3):317-27. PubMed ID: 16516835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and characterization of an improved protein tyrosine phosphatase substrate-trapping mutant.
    Xie L; Zhang YL; Zhang ZY
    Biochemistry; 2002 Mar; 41(12):4032-9. PubMed ID: 11900546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
    He HY; Zheng J; Li Y; Heng WJ; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eyes absent proteins: characterization of substrate specificity and phosphatase activity of mutants associated with branchial, otic and renal anomalies.
    Musharraf A; Markschies N; Teichmann K; Pankratz S; Landgraf K; Englert C; Imhof D
    Chembiochem; 2008 Sep; 9(14):2285-94. PubMed ID: 18759246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrostatic evaluation of the signature motif (H/V)CX5R(S/T) in protein-tyrosine phosphatases.
    Peters GH; Frimurer TM; Olsen OH
    Biochemistry; 1998 Apr; 37(16):5383-93. PubMed ID: 9548920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.
    Zhang EE; Chapeau E; Hagihara K; Feng GS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16064-9. PubMed ID: 15520383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
    Chen L; Sung SS; Yip ML; Lawrence HR; Ren Y; Guida WC; Sebti SM; Lawrence NJ; Wu J
    Mol Pharmacol; 2006 Aug; 70(2):562-70. PubMed ID: 16717135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SHP2 binds catalase and acquires a hydrogen peroxide-resistant phosphatase activity via integrin-signaling.
    Yano S; Arroyo N; Yano N
    FEBS Lett; 2004 Nov; 577(3):327-32. PubMed ID: 15556604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia.
    Xu R; Yu Y; Zheng S; Zhao X; Dong Q; He Z; Liang Y; Lu Q; Fang Y; Gan X; Xu X; Zhang S; Dong Q; Zhang X; Feng GS
    Blood; 2005 Nov; 106(9):3142-9. PubMed ID: 16030196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.